FDA Issues Guidances on Dual 510(k) and CLIA Waiver Applications
The US Food and Drug Administration (FDA) finalized two guidance’s providing recommendation for Dual 510(k) and CLIA Waiver by Application Studies. The purpose of this guidance is to help manufacturers...